1. 2019
  2. Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4)

    Voorwerk, L., Slagter, M., Horlings, H. M., Sikorska, K., van de Vijver, K. K., de Maaker, M., Nederlof, I., Kluin, R. J. C., Warren, S., Ong, S., Wiersma, T. G., Russell, N. S., Lalezari, F., Schouten, P. C., Bakker, N. A. M., Ketelaars, S. L. C., Peters, D., Lange, C. A. H., van Werkhoven, E., van Tinteren, H. & 14 othersMandjes, I. A. M., Kemper, I., Onderwater, S., Chalabi, M., Wilgenhof, S., Haanen, J. B. A. G., Salgado, R., de Visser, K. E., Sonke, G. S., Wessels, L. F. A., Linn, S. C., Schumacher, T. N., Blank, C. U. & Kok, M., Jul 2019, In : Nature medicine. 25, 7, p. 1175

    Research output: Contribution to journalErratum/CorrigendumAcademic

  3. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

    Voorwerk, L., Slagter, M., Horlings, H. M., Sikorska, K., van de Vijver, K. K., de Maaker, M., Nederlof, I., Kluin, R. J. C., Warren, S., Ong, S., Wiersma, T. G., Russell, N. S., Lalezari, F., Schouten, P. C., Bakker, N. A. M., Ketelaars, S. L. C., Peters, D., Lange, C. A. H., van Werkhoven, E., van Tinteren, H. & 14 othersMandjes, I. A. M., Kemper, I., Onderwater, S., Chalabi, M., Wilgenhof, S., Haanen, J. B. A. G., Salgado, R., de Visser, K. E., Sonke, G. S., Wessels, L. F. A., Linn, S. C., Schumacher, T. N., Blank, C. U. & Kok, M., Jun 2019, In : Nature medicine. 25, 6, p. 920-928 9 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  4. The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients with Oropharyngeal Cancer

    Gouw, Z. A. R., la Fontaine, M. D., van Kranen, S., van de Kamer, J. B., Vogel, W. V., van Werkhoven, E., Sonke, J-J. & Al-Mamgani, A., May 2019, In : Clinical nuclear medicine. 44, 5, p. E323-E328

    Research output: Contribution to journalArticleAcademicpeer-review

  5. A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy

    Henricks, L. M., Lunenburg, C. A. T. C., de Man, F. M., Meulendijks, D., Frederix, G. W. J., Kienhuis, E., Creemers, G-J., Baars, A., Dezentjé, V. O., Imholz, A. L. T., Jeurissen, F. J. F., Portielje, J. E. A., Jansen, R. L. H., Hamberg, P., ten Tije, A. J., Droogendijk, H. J., Koopman, M., Nieboer, P., van de Poel, M. H. W., Mandigers, C. M. P. W. & 11 othersRosing, H., Beijnen, J. H., van Werkhoven, E., van Kuilenburg, A. B. P., van Schaik, R. H. N., Mathijssen, R. H. J., Swen, J. J., Gelderblom, H., Cats, A., Guchelaar, H-J. & Schellens, J. H. M., 2019, In : European journal of cancer (Oxford, England. 107, p. 60-67

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Always randomize as late as possible

    van Werkhoven, E., Tajik, P. & Bossuyt, P. M., 2019, In : Gastric cancer.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  7. Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR)

    Dabestani, S., Beisland, C., Stewart, G. D., Bensalah, K., Gudmundsson, E., Lam, T. B., Gietzmann, W., Zakikhani, P., Marconi, L., Fernandéz-Pello, S., Monagas, S., Williams, S. P., Torbrand, C., Powles, T., van Werkhoven, E., Meijer, R., Volpe, A., Staehler, M., Ljungberg, B. R. & Bex, A., 2019, In : European urology. 75, 2, p. 261-264

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Neutropenia and docetaxel exposure in metastatic castration-resistant prostate cancer patients: A meta-analysis and evaluation of a clinical cohort

    de Vries Schultink, A. H. M., Crombag, M-R. B. S., van Werkhoven, E., Otten, H-M., Bergman, A. M., Schellens, J. H. M., Huitema, A. D. R. & Beijnen, J. H., 2019, In : Cancer medicine. 8, 4, p. 1406-1415

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort Analysis

    Heukelom, J., Navran, A., Gouw, Z. A. R., Tesselaar, M. E., Zuur, C. L., van Werkhoven, E., Sonke, J-J., Rasch, C. R. N. & Al-Mamgani, A., 2019, In : Otolaryngology-head and neck surgery.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Prognostic value of residual disease after neoadjuvant therapy in HER2-positive breast cancer evaluated by residual cancer burden, neoadjuvant response index, and Neo-BioSCore

    Steenbruggen, T. G., van Seijen, M., Janssen, L. M., van Ramshorst, M. S., van Werkhoven, E., Vrancken Peeters, M-J. T. D. F., Wesseling, J., Lips, E. H. & Sonke, G. S., 2019, In : Clinical cancer research. 25, 16, p. 4985-4992

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

    Kwakman, J. J. M., van Werkhoven, E., Simkens, L. H. J., van Rooijen, J. M., van de Wouw, Y. A. J., Tije, A. J. T., Creemers, G-J. M., Hendriks, M. P., Los, M., van Alphen, R. J., Polée, M. B., Muller, E. W., van der Velden, A. M. T., van Voorthuizen, T., Koopman, M., Mol, L. & Punt, C. J. A., 2019, In : Clinical colorectal cancer. 18, 2, p. e229-e230

    Research output: Contribution to journalComment/Letter to the editorAcademic

Previous 1 2 3 Next

ID: 113140